Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Merus B.V.
M.D. Anderson Cancer Center
Pfizer
Syndax Pharmaceuticals
The Methodist Hospital Research Institute
M.D. Anderson Cancer Center
UNICANCER
Incyte Corporation
Region Skane
DEKA Biosciences
Sixth Affiliated Hospital, Sun Yat-sen University
Assistance Publique - Hôpitaux de Paris
Shengjing Hospital
Fudan University
Anhui Provincial Hospital
Persephone Biosciences
Celldex Therapeutics
Oslo University Hospital
Alliance for Clinical Trials in Oncology
Fudan University
Fudan University
Zhejiang University
Sun Yat-sen University
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Zhejiang University
Amgen
Fudan University
Second Affiliated Hospital, School of Medicine, Zhejiang University
State Scientific Centre of Coloproctology, Russian Federation
Dana-Farber Cancer Institute
Fudan University
Chinese PLA General Hospital
UNICANCER
Federation Francophone de Cancerologie Digestive
Fudan University
University of Leicester
Sinocelltech Ltd.
University of Wisconsin, Madison
Peking University
UNICANCER
Hoffmann-La Roche
Shanghai University of Traditional Chinese Medicine
University of Roma La Sapienza
Hoffmann-La Roche
Azienda Ospedaliero, Universitaria Pisana
Chinese University of Hong Kong
Boston Scientific Corporation
Jules Bordet Institute
Shenzhen Hornetcorn Bio-technology Company, LTD